CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile

References

• Awade AC, Cleuziat P, Gonzales T, Robert-Baudouy J. Pyrrolidone carboxyl peptidase (Pcp): An enzyme that removes pyroglutamic acid (pGlu) from pGlu-peptides and pGlu-proteins. Proteins 1994;20:34–51.
   PubMed Web of Science ®Google Scholar
• Van Coillie E, Proost P, Van Aelst I, Struyf S, Polfliet M, De Meester I, Harvey DJ, Van Damme J, Opdenakker G. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase iv. Biochemistry 1998;37:12672–12680.
   PubMedGoogle Scholar
• Busby WH, Jr., Quackenbush GE, Humm J, Youngblood WW, Kizer JS. An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. J Biol Chem 1987;262:8532–8536.
   PubMedGoogle Scholar
• Sykes PA, Watson SJ, Temple JS, Bateman RC Jr.. Evidence for tissue-specific forms of glutaminyl cyclase. FEBS Lett 1999;455:159–161.
   PubMed Web of Science ®Google Scholar
• Bockers TM, Kreutz MR, Pohl T. Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary. J Neuroendocrinol 1995;7:445–453.
   PubMed Web of Science ®Google Scholar
• Pohl T, Zimmer M, Mugele K, Spiess J. Primary structure and functional expression of a glutaminyl cyclase. Proc Natl Acad Sci USA 1991;88:10059–10063.
   PubMed Web of Science ®Google Scholar
• Morgan C, Colombres M, Nunez MT, Inestrosa NC. Structure and function of amyloid in Alzheimer’s disease. Prog Neurobiol 2004;74:323–349.
   PubMedGoogle Scholar
• Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, Holzer M, Hutter-Paier B, Prokesch M, Windisch M, Jagla W, Schlenzig D, Lindner C, Rudolph T, Reuter G, Cynis H, Montag D, Demuth HU, Rossner S. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology. Nat Med 2008;14:1106–1111.
   PubMed Web of Science ®Google Scholar
• Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 2005;44:10810–10821.
   PubMed Web of Science ®Google Scholar
• Schilling S, Hoffmann T, Manhart S, Hoffmann M, Demuth HU. Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions. FEBS Lett 2004;563:191–196.
   PubMedGoogle Scholar
• Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, Bohm G, Demuth HU. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 2006;45:12393–12399.
   PubMed Web of Science ®Google Scholar
• Youssef I, Florent-Bechard S, Malaplate-Armand C, Koziel V, Bihain B, Olivier JL, Leininger-Muller B, Kriem B, Oster T, Pillot T. N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis. Neurobiol Aging 2008;29:1319–1333.
   PubMedGoogle Scholar
• Russo C, Violani E, Salis S, Venezia V, Dolcini V, Damonte G, Benatti U, D’Arrigo C, Patrone E, Carlo P, Schettini G. Pyroglutamate-modified amyloid beta-peptides-abetaN3(pE)-strongly affect cultured neuron and astrocyte survival. J Neurochem 2002;82:1480–1489.
   PubMed Web of Science ®Google Scholar
• Buchholz M, Hamann A, Aust S, Brandt W, Bohme L, Hoffmann T, Schilling S, Demuth HU, Heiser U. Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement. J Med Chem 2009;52:7069–7080.
   PubMed Web of Science ®Google Scholar
• Dragon software version 3.0-2003 and manual. Todeschini R, Consonni V, Mauri A, Pavan M. Milano, Italy. http://disat.Unimib.It/chm/Dragon.Htm.
   Google Scholar
• Prabhakar YS. A combinatorial approach to the variable selection in multiple linear regression analysis of Selwood et al. data set- A case study. QSAR Comb Sci 2003;22:583–595.
   Google Scholar
• Gupta MK, Prabhakar YS. Topological descriptors in modeling the antimalarial activity of 4-(3’,5’-disubstituted anilino)quinolines. J Chem Inf Model 2006;46:93–102.
   PubMed Web of Science ®Google Scholar
• Saquib M, Gupta MK, Sagar R, Prabhakar YS, Shaw AK, Kumar R, Maulik PR, Gaikwad AN, Sinha S, Srivastava AK, Chaturvedi V, Srivastava R, Srivastava BS. C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study. J Med Chem 2007;50:2942–2950.
   PubMed Web of Science ®Google Scholar
• ChemDraw Ultra 6.0 and Chem3D Ultra, Cambridge Soft Corporation, Cambridge, USA.
   Google Scholar
• Prabhakar YS, Rawal RK, Gupta MK, Katti SB. CP-MLR/PLS directed structure-activity modeling of the HIV-1RT inhibitory activity of 2,3-diaryl-1,3-thiazolidin-4-ones. QSAR Comb Sci 2004;23:234–244.
   Google Scholar
• Gupta MK, Sagar R, Shaw AK, Prabhakar YS. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols-topological descriptors in modeling the activity. Bioorg Med Chem 2005;13:343–351.
   PubMed Web of Science ®Google Scholar
• Prabhakar YS, Gupta MK, Roy N, Venkateswarlu Y. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity. J Chem Inf Model 2006;46:86–92.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Prabhakar YS. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity. Eur J Med Chem 2008;43:2751–2767.
   PubMed Web of Science ®Google Scholar
• Sharma S, Sharma BK, Prabhakar YS. Juglone derivatives as antitubercular agents: a rationale for the activity profile. Eur J Med Chem 2009;44:2847–2853.
   PubMedGoogle Scholar
• Akaike H. Information theory and an extension of the minimum likelihood principle. Akademiai kiado: Budapest. 1973:267–281.
   Google Scholar
• Akaike H. A new look at the statistical identification model. IEEE Trans Autom Control 1974:AC-19:716–723.
   Web of Science ®Google Scholar
• Kubinyi H. Variable selection in QSAR studies. I. An evolutionary algorithm. Quant Struct-Act Relat 1994;13:285–294.
   Google Scholar
• Kubinyi H. Variable selection in QSAR studies. II. A highly efficient combination of systematic search and evolution. Quant Struct-Act Relat 1994;13:393–401.
   Google Scholar
• Friedman J. Technical Report No. 102. Laboratory for Computational Statistics. In Stanford University: Stanford; 1990.
   Google Scholar
• Sharma BK, Pilania P, Singh P. Modeling of cyclooxygenase-2 and 5-lipooxygenase inhibitory activity of apoptosis-inducing agents potentially useful in prostate cancer chemotherapy: derivatives of diarylpyrazole. J Enzyme Inhib Med Chem 2009;24:607–615.
   PubMed Web of Science ®Google Scholar
• Broto P, Moreau G, Vandycke C. Molecular structures: perception. Autocorrelation descriptor and SAR studies. Eur J Med Chem -Chim Ther 1984;19:66–70.
   Web of Science ®Google Scholar
• Viswanadhan VN, Ghose AK, Revankar GR, Robins RK. Atomic physicochemical parameters for three dimensional structure directed Quantitative Structure-Activity Relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci 1989;29:163–172.
   Google Scholar
• Wold S. Cross-validatory estimation of the number of components in factor and principal component models. Technometrics 1978;20:397–405.
   Web of Science ®Google Scholar